The drug Torisel belongs to the group of anticancer drugs, protein tyrosine kinase inhibitors. It is based on temsirolimus, an active substance that is highly effective in the fight against cancer pathologies. The medication is produced in the form of a concentrated solution for injection.
The maximum effectiveness of the drug was found in the treatment of the following oncological diseases:
– Advanced renal cell carcinoma;
– Recurrent form of lymphoma from elements located in the mantle area;
– Refractory cell lymphoma of the mantle region.
Active substance: temsirolimus
Prescription medicine